Correlation Between DiaMedica Therapeutics and ABVC Biopharma
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and ABVC Biopharma, you can compare the effects of market volatilities on DiaMedica Therapeutics and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and ABVC Biopharma.
Diversification Opportunities for DiaMedica Therapeutics and ABVC Biopharma
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between DiaMedica and ABVC is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and ABVC Biopharma go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and ABVC Biopharma
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.12 times more return on investment than ABVC Biopharma. However, DiaMedica Therapeutics is 1.12 times more volatile than ABVC Biopharma. It trades about 0.23 of its potential returns per unit of risk. ABVC Biopharma is currently generating about -0.1 per unit of risk. If you would invest 423.00 in DiaMedica Therapeutics on September 12, 2024 and sell it today you would earn a total of 93.00 from holding DiaMedica Therapeutics or generate 21.99% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 95.45% |
Values | Daily Returns |
DiaMedica Therapeutics vs. ABVC Biopharma
Performance |
Timeline |
DiaMedica Therapeutics |
ABVC Biopharma |
DiaMedica Therapeutics and ABVC Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DiaMedica Therapeutics and ABVC Biopharma
The main advantage of trading using opposite DiaMedica Therapeutics and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
ABVC Biopharma vs. Equillium | ABVC Biopharma vs. DiaMedica Therapeutics | ABVC Biopharma vs. Valneva SE ADR | ABVC Biopharma vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
CEOs Directory Screen CEOs from public companies around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |